Genmab — November 2024

[ProinvestorNEWS]

Tak for link Stockbull. Videoen er lagt i debatten. https://proinvestor.com/boards/122847

[E_L]

Novartis feeling good about their SC injection, they start a trial to compare the experiences, including injection-related reactions (IRRs) of patients newly receiving ofatumumab to those starting to receive ocrelizumab SC formulation - Multiple Sclerosis Patient Experience on Kesimpta and Ocrevus Subcutaneous Formulation (MS-PEKOS) https://clinicaltrials.gov/study/NCT06668324

[Vitus]

Genmab er pt en bedrøvelig affære at kigge på….der må være lagt op til en eksplosion af en eller andet art …..

[w]

træls at det tilbagekøbsprogram skulle fyres af så hurtigt

[StockBull]

bliver nok annonceret et nyt i næste uge

[w]

det ville da være herligt

[E_L]

https://www.jyskebank.dk/pdf/wcm/8a6304b6-23c4-4d94-8b81-9adbe18cdacd/Danske+Aktier+Oktober+2024+RR.pdf?MOD=AJPERES jyskebank monthly

[E_L]

Michigan Oncologist Charged in Scheme to Illegally Sell Cancer Drugs -According to the indictment, Aslam acquired and sold more than $17 million in cancer drugs and personally netted more than $2.5 million during the scheme. https://www.medscape.com/viewarticle/michigan-oncologist-charged-scheme-illegally-sell-cancer-2024a1000jz0?form=fpf

[E_L]

BioNTech to Host Innovation Series R&D Day on November 14, 2024 -could be interesting for us

[Raun]

Why E L?

[Raun]

Puha, hvis der skulle komme et nyt opkøbsprogram, så falder mine gisninger helt fra hinanden...

[StockBull]

sjovt nok har JB og JPM samme omsætning og nettoresultat for 2025 og 2026 men 12 mdr target 2050 vs. 2400. for 2024 ligger JB 1 mia kr lavere i nettoresultat 4844/5874, mystisk

[StockBull]

JPM har 50% på opt-in. kan være JB regner med 80-90% og derfor de 2400 JPM 5 bn usd i peaksale HexaBody-CD38, JB måske højere

[StockBull]

så uden opt-in nedjustere begge nok til omkring 1750 i target hvis det skulle ende med det

[gentogen]

Nu siger JB jo, at "Der er ingen tvivl om, at afklaringen på HexaBody-CD38 bliver afgørende for Genmab, men markedets lidt entydige fokus på dette event mener vi også er fejlagtigt."

[E_L]

you mean why the Biontech R&D Day could be interesting Raun? Because they may say something about the antibodies we have in partnership with them , with GEN1042 being of the most interest for now

[bikube]

Halo stiger over 12% efter regnskabet i går, det vil jeg da godt se Genmab følge.

[lahn1]

Knock-your-socks-off-News. https://www.linkedin.com/pulse/knock-your-socks-off-news-november-2024-genmab-uname?utm_source=share&utm_medium=member_ios&utm_campaign=share_via

[peter12]

@EL yesterday 14:10, could it be related to this combination ? https://patents.google.com/patent/JP2024109764A

[peter12]

English version https://patents.google.com/patent/AU2019266205A1/en